Kelly Deck - 06 May 2024 Form 4 Insider Report for Inhibrx, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INBX	Stock Option (right to buy)	Options Exercise	$603,446	-17,624	-100%	$34.24	0	06 May 2024	Common Stock	17,624	$10.52	Direct	F1
transaction	INBX	Stock Option (right to buy)	Options Exercise	$71,459	-2,087	-100%	$34.24	0	06 May 2024	Common Stock	2,087	$11.25	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F2	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on April 21, 2021, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.